Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 233-221-8 | CAS number: 10094-34-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Developmental toxicity / teratogenicity
Administrative data
- Endpoint:
- developmental toxicity
- Remarks:
- Prenatal developmental toxicity study
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 020
- Report date:
- 2020
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 414 (Prenatal Developmental Toxicity Study)
- GLP compliance:
- yes (incl. QA statement)
- Limit test:
- yes
Test material
- Reference substance name:
- α,α-dimethylphenethyl acetate
- EC Number:
- 205-781-3
- EC Name:
- α,α-dimethylphenethyl acetate
- Cas Number:
- 151-05-3
- Molecular formula:
- C12H16O2
- IUPAC Name:
- 1,1-dimethyl-2-phenylethyl acetate
- Test material form:
- solid
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Details on test animals or test system and environmental conditions:
- A total number of 80 (30 male and 50 female) Sprague Dawley rats of about 12 to 13 weeks were received along with their health certificate for the Study.
Rats were housed in an experimental room maintained at 20.1 to 23.6 °C and 51 to 66% relative humidity with adequate fresh air supply (minimum 12 air changes/hour). Light and dark cycles of 12 hours, each were maintained throughout the experimental phase.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- other: 0.1% Tween 80 (polysorbate 80, polyoxyethylene sorbitan monooleate) in water
- Details on mating procedure:
- After completion of acclimatization period, females were housed with males for pairing or cohabitation based on 1:1 ratio (one male: one female) for 14 days or until the evidence of mating, whichever is earlier. Each day, the evidence of mating was confirmed by presence of sperms in the vaginal lavage. The day of presence of sperms in the vaginal lavage was considered as day ‘0’ of the pregnancy or ‘GD 0 – (Gestation Day – 0)’ for the particular female. Subsequently, post detection of sperms in the vaginal lavage, females were separated from the male partner and housed individually through gestation period until their euthanasia on day 20 of gestation (GD20).
The cohabitation or pairing was done till availability of sufficient number (50 female) of confirmed mating (sperm positive in vaginal lavage) females. Sufficient number of confirmed mated females are achieved within 11 days.
After completion of successful cohabitation period, all the males were sent back to VBS animal holding/stock and extra females (both mated but negative for sperms and non-mated) was sent for euthanasia. - Frequency of treatment:
- The vehicle (G1 - 0.1% Tween 80) and the test item, Dimethyl Benzyl Carbinyl Acetate (G2: 1000 mg/kg body weight) was administered orally gavage once daily to the pregnant females starting from Gestation Day 5 (GD 5) to till 19 (GD 19) of the respective females.
Doses / concentrations
- Dose / conc.:
- 10 mg/kg bw/day (nominal)
Results and discussion
Results: maternal animals
General toxicity (maternal animals)
- Clinical signs:
- no effects observed
- Description (incidence and severity):
- There were no treatment related clinical signs noticed in females of vehicle control (G1- 0
mg/kg body weight) and limit test Dose- G2 1000 mg/kg body weight throughout the
experiment period. - Mortality:
- no mortality observed
- Description (incidence):
- There were no mortality and morbidity in the present study in vehicle control G1 and limit
test Dose- G2 1000 mg/kg body weight. - Body weight and weight changes:
- no effects observed
- Description (incidence and severity):
- There were no treatment related statistical significant changes noticed in the body weights,
body weight gain and feed consumption on female from limit dose G2 group animals when
compared with G1 group animals. - Food consumption and compound intake (if feeding study):
- no effects observed
- Description (incidence and severity):
- No statistical significant changes were observed in female of G2 group when compared
with G1 group females. - Organ weight findings including organ / body weight ratios:
- no effects observed
- Description (incidence and severity):
- On completion of the gross pathology examination, no abnormalities were observed in any
of the organs in gross pathology examination and no organs were collected and preserved. - Gross pathological findings:
- no effects observed
- Description (incidence and severity):
- External examination of none of the terminally euthanized female animals belonging to the
control (G1) and limit dose groups G2) did not revealed any external and internal
abnormalities, during gross pathology observation. - Neuropathological findings:
- no effects observed
- Description (incidence and severity):
- External examination of none of the terminally euthanized female animals belonging to the
control (G1) and limit dose groups G2) did not revealed any external and internal
abnormalities, during gross pathology observation.
Maternal developmental toxicity
- Details on maternal toxic effects:
- Evaluation of maternal parameters viz: gravid uteri, total implantation, live fetus, number of corpora lutea, implantation sites, early and late resorptions, pre implantation loss, did not show any statistically significant difference in the treated groups as compared with vehicle control.
Effect levels (maternal animals)
- Dose descriptor:
- NOAEL
- Effect level:
- 1 000 mg/kg bw/day (nominal)
- Basis for effect level:
- body weight and weight gain
Results (fetuses)
- Description (incidence and severity):
- Total placenta weight, did not show any statistically significant difference in the treated groups as compared with vehicle control. Whereas, statistical significance decrease in male and female combined fetuses weight, male fetuses weight and female fetus weight in G2 and increase in anogenital distance (AGD) in male and female pups in G2 group as compared with vehicle control G1. Although statistically significant, above these parameters did not correlate with any other parameters/observations. Therefore, these significances have been considered as spontaneous/ incidental findings unrelated with the test item treatment as compared to control group G1.
- Details on embryotoxic / teratogenic effects:
- There was no treatment related external, visceral, head- razor and skeletal abnormalities in the pups from the test item, Dimethyl Benzyl Carbinyl Acetate in control and treated groups. The abnormalities showed in the male and female pups were incidental and comparable.
Effect levels (fetuses)
- Dose descriptor:
- NOAEL
- Effect level:
- 1 000 mg/kg bw/day (nominal)
- Sex:
- male/female
- Basis for effect level:
- fetal/pup body weight changes
Overall developmental toxicity
- Developmental effects observed:
- no
Applicant's summary and conclusion
- Conclusions:
- To conclude, based on overall observations and under the circumstances of the present study, the test item, Dimethyl Benzyl Carbinyl Acetate when administered at 0, and 1000 mg/kg body weight by oral gavage route in Sprague Dawley rats for (GD 5-19) days did not produce any treatment related effects on the body weights or body weight gain/loss, feed consumption and fetal abnormalities. There were no treatment related clinical signs noticed in females all the dose levels. Based on the above observations, the dose of 1000 mg/kg body weight has been considered as No Observed Adverse Effect Level (NOAEL) for maternal toxicity and embryo fetal toxicity of the test item, Dimethyl Benzyl Carbinyl Acetate in Sprague Dawley rats.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

Route: .live2